John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$153M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$130M |
| 3 |
Cummins
CMI
|
+$121M |
| 4 |
Lowe's Companies
LOW
|
+$104M |
| 5 |
American Express
AXP
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$445M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$200M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$165M |
| 4 |
Gilead Sciences
GILD
|
+$158M |
| 5 |
Microsoft
MSFT
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.25% |
| 2 | Healthcare | 12.59% |
| 3 | Industrials | 11.99% |
| 4 | Financials | 10.09% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
ICU Medical
ICUI
$4.57B
| $8.6M | 0.04% |
76,254
-5,171
| -6% | -$571K |
|
477
CALL
SLB Ltd
SLB
$79.9B
| $8.51M | 0.04% |
122,000
+49,000
| +67% | +$3.67M |
|
478
Teekay
TK
$1.16B
| $8.48M | 0.04% |
858,760
+827,911
| +2,684% | +$21.6M |
|
|
UNIT
479
Uniti Group
UNIT
$2.42B
| $8.47M | 0.04% |
453,255
+401,782
| +781% | +$7.74M |
|
480
Wells Fargo
WFC
$254B
| $8.45M | 0.04% |
155,487
-831,222
| -84% | -$45.1M |
|
481
Blackstone Mortgage Trust
BXMT
$2.41B
| $8.38M | 0.04% |
313,263
+42,010
| +15% | +$1.17M |
|
|
ACOR
482
DELISTED
Acorda Therapeutics
ACOR
| $8.38M | 0.04% |
+1,632
| New | +$7.13M |
|
483
Casey's General Stores
CASY
$30.9B
| $8.37M | 0.04% |
+69,447
| New | +$7.93M |
|
484
PUT
RTX Corp
RTX
$283B
| $8.36M | 0.04% |
+138,243
| New | +$8.37M |
|
|
BID
485
DELISTED
Sotheby's
BID
| $8.35M | 0.04% |
+324,020
| New | +$9.82M |
|
486
Cabot Corp
CBT
$4.4B
| $8.32M | 0.04% |
203,518
+170,925
| +524% | +$6.76M |
|
|
IM
487
DELISTED
Ingram Micro
IM
| $8.32M | 0.04% |
273,833
+68,465
| +33% | +$2.07M |
|
|
MGLN
488
DELISTED
Magellan Health Services, Inc.
MGLN
| $8.29M | 0.04% |
+134,512
| New | +$7.22M |
|
|
NBIS
489
Nebius Group N.V.
NBIS
$59.6B
| $8.29M | 0.04% |
+527,013
| New | +$7.88M |
|
490
PUT
Micron Technology
MU
$1.09T
| $8.28M | 0.04% |
585,000
+304,800
| +109% | +$4.87M |
|
|
MDVN
491
DELISTED
MEDIVATION, INC.
MDVN
| $8.25M | 0.04% |
170,738
-156,813
| -48% | -$6.77M |
|
|
FCE.A
492
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $8.25M | 0.04% |
376,018
-203,570
| -35% | -$4.44M |
|
|
493
CALL
Micron Technology
MU
$1.09T
| $8.24M | 0.04% |
581,700
+187,700
| +48% | +$3M |
|
494
Scotiabank
BNS
$107B
| $8.22M | 0.04% |
207,546
-886,430
| -81% | -$38.3M |
|
495
iShares Russell 2000 Value ETF
IWN
$14.6B
| $8.19M | 0.04% |
+89,000
| New | +$8.45M |
|
|
EMBJ
496
Embraer S.A. ADS
EMBJ
$13.5B
| $8.18M | 0.04% |
276,951
+240,313
| +656% | +$7.04M |
|
|
GGP
497
DELISTED
GGP Inc.
GGP
| $8.18M | 0.04% |
300,471
-137,682
| -31% | -$3.7M |
|
498
Essex Property Trust
ESS
$18.6B
| $8.13M | 0.04% |
33,973
-39,021
| -53% | -$8.96M |
|
|
NFX
499
DELISTED
Newfield Exploration
NFX
| $8.13M | 0.04% |
+249,607
| New | +$9.3M |
|
500
BWX Technologies
BWXT
$14.4B
| $8.06M | 0.04% |
253,590
+40,030
| +19% | +$1.18M |
|
Similar funds
John Overdeck's Q4 2015 Portfolio in Review
As of Q4 2015, John Overdeck held 3,233 positions worth $20.9B, up 6.8% from $19.5B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
John Overdeck deployed $631M of net new capital in Q4 2015, opening 1,109 new positions and adding to 884 existing holdings. Its largest new stake was American Express: 1,381,273 shares worth $96.1M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $158M trimmed.
- John Overdeck's largest Q4 2015 buy was American Express: 1,381,273 shares worth $96.1M.
- John Overdeck added most to Allergan plc in Q4 2015, an estimated $153M increase.
- John Overdeck's biggest Q4 2015 reduction was Gilead Sciences, cutting an estimated $158M.
- John Overdeck fully exited State Street SPDR S&P 500 ETF Trust in Q4 2015, selling an estimated $445M.
- John Overdeck's ten largest holdings make up 8% of its $20.9B portfolio in Q4 2015.
- John Overdeck opened 1,109 new positions and closed 598 in Q4 2015.
- John Overdeck's portfolio value rose 6.8% quarter-over-quarter to $20.9B.
Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.